Supernus Pharmaceuticals Inc (SUPN)
30.19
+0.21
(+0.70%)
USD |
NASDAQ |
Apr 24, 12:27
Supernus Pharmaceuticals Total Liabilities (Quarterly): 356.16M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 356.16M |
| September 30, 2023 | 372.97M |
| June 30, 2023 | 373.19M |
| March 31, 2023 | 879.66M |
| December 31, 2022 | 816.30M |
| September 30, 2022 | 840.33M |
| June 30, 2022 | 853.54M |
| March 31, 2022 | 811.07M |
| December 31, 2021 | 873.30M |
| September 30, 2021 | 744.57M |
| June 30, 2021 | 787.48M |
| March 31, 2021 | 753.00M |
| December 31, 2020 | 759.24M |
| September 30, 2020 | 801.14M |
| June 30, 2020 | 825.05M |
| March 31, 2020 | 576.48M |
| December 31, 2019 | 564.85M |
| September 30, 2019 | 549.65M |
| June 30, 2019 | 540.77M |
| March 31, 2019 | 545.43M |
| December 31, 2018 | 524.79M |
| September 30, 2018 | 500.58M |
| June 30, 2018 | 462.31M |
| March 31, 2018 | 473.29M |
| December 31, 2017 | 156.98M |
| Date | Value |
|---|---|
| September 30, 2017 | 133.82M |
| June 30, 2017 | 116.97M |
| March 31, 2017 | 116.19M |
| December 31, 2016 | 117.81M |
| September 30, 2016 | 111.74M |
| June 30, 2016 | 77.61M |
| March 31, 2016 | 66.34M |
| December 31, 2015 | 100.62M |
| September 30, 2015 | 57.33M |
| June 30, 2015 | 51.80M |
| March 31, 2015 | 45.05M |
| December 31, 2014 | 96.08M |
| September 30, 2014 | 60.21M |
| June 30, 2014 | 60.82M |
| March 31, 2014 | 68.51M |
| December 31, 2013 | 77.53M |
| September 30, 2013 | 111.31M |
| June 30, 2013 | 96.08M |
| March 31, 2013 | 37.79M |
| December 31, 2012 | 36.42M |
| September 30, 2012 | 42.38M |
| June 30, 2012 | 41.98M |
| March 31, 2012 | 42.93M |
| December 31, 2011 | 44.29M |
| September 30, 2011 | 104.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
356.16M
Minimum
Dec 2023
879.66M
Maximum
Mar 2023
688.36M
Average
759.24M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Dynavax Technologies Corp | 375.02M |
| Ligand Pharmaceuticals Inc | 86.30M |
| Pacira BioSciences Inc | 704.26M |
| Esperion Therapeutics Inc | 660.79M |
| Collegium Pharmaceutical Inc | 947.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.278B |
| Shareholders Equity (Quarterly) | 921.52M |
| Current Ratio | 1.699 |
| Net Debt Paydown Yield | 5.07% |